Intra-articular fms-like tyrosine kinase 3 ligand expression is a driving force in induction and progression of arthritis

PLoS ONE

Volumn 3, Issue 11, 2008, Pages

  Dehlin, Mats ^a   Bokarewa, Maria ^a   Rottapel, Robert ^b   Foster, Simon J ^c   Magnusson, Mattias ^a   Dalhberg, Leif E ^d   Tarkowski, Andrej ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD135 ANTIGEN; PEPTIDOGLYCAN; TOLL LIKE RECEPTOR 2; BACTERIAL PROTEIN; FLT3 LIGAND PROTEIN; IMMUNOLOGICAL ADJUVANT; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE INDUCTION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; JOINT CAVITY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; ANIMAL; B LYMPHOCYTE; BAGG ALBINO MOUSE; BLOOD; DISEASE MODEL; IMMUNOLOGY; INTRAARTICULAR DRUG ADMINISTRATION; KNEE; MIDDLE AGED; MOUSE; PATHOLOGY; TRANSPLANTATION;

MUS;

ADJUVANTS, IMMUNOLOGIC; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ARTHRITIS, RHEUMATOID; B-LYMPHOCYTES; BACTERIAL PROTEINS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; HUMANS; INJECTIONS, INTRA-ARTICULAR; KNEE JOINT; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MIDDLE AGED; PEPTIDOGLYCAN; SYNOVIAL FLUID; YOUNG ADULT;

EID: 56149110548     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0003633     Document Type: Article

References (12)

1. Firestein GS (2003) Evolving concepts of rheumatoid arthritis. Nature 423: 356-361.
2. Rosnet O, Buhring HJ, Marchetto S, Rappold I, Lavagna C, et al. (1996) Human FLT3/FLK2 receptor tyrosine kinase is expressed at the surface of normal and malignant hematopoietic cells. Leukemia 10: 238-248.
3. Rosnet O, Schiff C, Pebusque MJ, Marchetto S, Tonnelle C, et al. (1993) Human FLT3/FLK2 gene: cDNA cloning and expression in hematopoietic cells. Blood 82: 1110-1119.
4. Rappold I, Ziegler BL, Kohler I, Marchetto S, Rosnet O, et al. (1997) Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinase. Blood 90: 111-125.
5. Rusten LS, Lyman SD, Veiby OP, Jacobsen SE (1996) The FLT3 ligand is a direct and potent stimulator of the growth of primitive and committed human CD34+ bone marrow progenitor cells in vitro. Blood 87: 1317-1325.
6. Namikawa R, Muench MO, de Vries JE, Roncarolo MG (1996) The FLK2/FLT3 ligand synergizes with interleukin-7 in promoting stromal-cell-independent expansion and differentiation of human fetal pro-B cells in vitro. Blood 87: 1881-1890.
7. Maraskovsky E, Daro E, Roux E, Teepe M, Maliszewski CR, et al. (2000) In vivo generation of human dendritic cell subsets by Flt3 ligand. Blood 96: 878-884.
8. Stirewalt DL, Radich JP (2003) The role of FLT3 in haematopoietic malignancies. Nat Rev Cancer 3: 650-665.
9. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315-324.
10. Liu ZQ, Deng GM, Foster S, Tarkowski A (2001) Staphylococcal peptidoglycans induce arthritis. Arthritis Res 3: 375-380.
11. Lean JM, Fuller K, Chambers TJ (2001) FLT3 ligand can substitute for macrophage colony-stimulating factor in support of osteoclast differentiation and function. Blood 98: 2707-2713.
12. Papayannopoulou T, Nakamoto B, Andrews RG, Lyman SD, Lee MY (1997) In vivo effects of Flt3/Flk2 ligand on mobilization of hematopoietic progenitors in primates and potent synergistic enhancement with granulocyte colony-stimulating factor. Blood 90: 620-629.